Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Stock data | 2023 | Change |
---|---|---|
Price | $18.00 | N/A |
Market Cap | $102.73M | N/A |
Shares Outstanding | 5.71M | 0.00% |
Employees | 1.27K | N/A |
Shareholder Equity | 3.12B | 11.49% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.28 | N/A |
P/S Ratio | 2.53 | N/A |
P/B Ratio | 0.03 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0014 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $40.53M | N/A |
Earnings | $4.31M | N/A |
EPS | 63.39 | N/A |
Earnings Yield | 3.52 | N/A |
Gross Margin | 0.6304 | N/A |
Operating Margin | 0.1075 | N/A |
Net income margin | 0.1064 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $50.47M | N/A |
Total Debt | $633.94K | N/A |
Cash on Hand | $24.23M | N/A |
Debt to Equity | 0.0043 | -17.63% |
Cash to Debt | $38.22 | 23.78% |
Current Ratio | $3.07 | 29.91% |